Fig. 3: Interactions between AGL and different Fabs.
a Side view of AGLType A and FabHBC-Fv domains in a semi-transparent surface representation, along with the atomic model in the same color as in Fig. 2a. The viral envelope membrane is indicated with a thick gray line. Interfaces are highlighted with dashed boxes. b Close-up view of the interface between FabHBC-VH and HBsAg boxed in (a). Key residues for the binding between FabHBC-VH and HBsAg are shown as sticks. c Close-up view of the interface between FabHBC-VL and HBsAg boxed in (a). Key residues for the binding between FabHBC-VL and HBsAg are shown as sticks. d Side view of AGLType B and FabH006-Fv domains in a semi-transparent surface representation, along with the atomic model in the same color as in Fig. 2c. The viral envelope membrane is indicated with a thick gray line. Interfaces are highlighted with dashed boxes. e–g Close-up views of the interfaces between FabH006-VH and HBsAg boxed in (d). Key residues for the binding between FabH006-VH and HBsAg are shown as sticks. h Close-up views of the interfaces between FabH006-VL and HBsAg boxed in (d). Key residues for the binding between FabH006-VL and HBsAg are shown as sticks.
